Loading...
| A03555 | Pages: NA | Dec 2021 | 4291 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Seasonal Influenza Vaccine Market
Request Now !Seasonal influenza is an acute viral infection, which can easily spread from person to person. In addition, seasonal influenza occurs during winter and can affect a person of any age group. Vaccination against seasonal influenza is known as seasonal influenza vaccine. The key factor that drives the growth of this market is the increase in incidences of influenza virus globally. However, limited production capacity as well as stringent regulations by governing bodies will be a major restraint for this market. Moreover, advancements in technology can improve the pace by which these vaccines are developed, thereby creating more lucrative opportunities for key market players.
The seasonal influenza vaccine market is segmented on the basis of product type, application, and geography. Based on product type this market is segmented into type A (H1N1), type A (H3N2), and type B. Based on age group this market is segmented into pediatrics, adolescence, adults, and elderly. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as GlaxoSmithKline plc, Sinovac Biotech Ltd., Changsheng Bio-Technology Co., Ltd., Ccbio SA, Aleph Biomedical, Sanofi S.A., Jiangsu Simcere Vaxtec Bio-pharmaceutical Co., Ltd., Dalian Hissen Bio-pharm, Abbott Laboratories, and Novartis International AG have also been provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 SEASONAL INFLUENZA VACCINE MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. TYPE A (H1N1)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. TYPE A (H3N2)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. TYPE B
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 SEASONAL INFLUENZA VACCINE MARKET, BY AGE GROUP
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. PEDIATRICS
5.2.1. Key market trends
5.3. ADOLESCENCE
5.3.1. Key market trends
5.4. ADULTS
5.4.1. Key market trends
5.5. ELDERLY
5.5.1. Key market trends
CHAPTER 6 SEASONAL INFLUENZA VACCINE MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Seasonal Influenza Vaccine Market by Product Type
6.2.5. North America Seasonal Influenza Vaccine Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Seasonal Influenza Vaccine Market by Product Type
6.3.5. Europe Seasonal Influenza Vaccine Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Seasonal Influenza Vaccine Market by Product Type
6.4.5. Asia-Pacific Seasonal Influenza Vaccine Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Seasonal Influenza Vaccine Market by Product Type
6.5.5. LAMEA Seasonal Influenza Vaccine Market by End User
CHAPTER 7 COMPANY PROFILES
7.1. GLAXOSMITHKLINE PLC
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. SINOVAC BIOTECH LTD.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. CHANGSHENG BIO-TECHNOLOGY CO., LTD.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. CCBIO SA
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ALEPH BIOMEDICAL
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. SANOFI S.A.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. JIANGSU SIMCERE VAXTEC BIO-PHARMACEUTICAL CO., LTD.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. DALIAN HISSEN BIO-PHARM
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. ABBOTT LABORATORIES
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. NOVARTIS INTERNATIONAL AG
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
